In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
73 News Items found
Dr. Zsofia Stadler
Finding
Preventing Lynch Syndrome Cancers: New Study Suggests Immunotherapy Could Work

An analysis of patients with Lynch syndrome treated at MSK finds that immunotherapy drugs called checkpoint inhibitors may prevent serious tumors from forming.
Emmanouil Pappou
Don’t Skip Routine Cancer Screenings: MSK Patient Shares How a Colonoscopy May Have Saved Her Life

Dr. Emmanouil Pappou urges the importance of routine cancer screenings, even during COVID-19, on the TODAY Show.
Amy Speck
Top Cancer Treatment Advances at MSK in 2024

Learn about some of the most important advances in cancer treatment and clinical trials at MSK in 2024.
Antonio Lekhrajmal is seen outdoors with his wife, Maria. He has been successfully treated with checkpoint inhibitors for advanced stomach cancer.
How Checkpoint Inhibitors for Stage 4 Stomach Cancer Worked for Antonio

Learn how MSK helped a man with stage 4 stomach (gastric) cancer using checkpoint inhibitors, a type of immunotherapy that also treats many other cancers.
A female nurse talks with a female patient, who is sitting in an exam chair
Feature
A Decade of Progress in Cancer Care, and What’s Next

Advances in diagnosis and treatment, especially those made over the past ten years, have played a significant role in the decline in cancer deaths. Learn about those advances — and what to expect in the next ten years.
Memorial Sloan Kettering neuro-oncologist Adrienne Boire
Roundup
Year in Review: Five Important Clinical Advances in Cancer in 2020

Read about some of the most important clinical advances made at MSK in 2020.
scale
Q&A
Why Are More Young Adults Getting Cancer? Obesity May Be to Blame

Cancer among younger Americans is on the rise, and much of it is linked to obesity. An MSK expert on diet and cancer explains what’s behind this disturbing new trend.
Piro Lito, Bob Li, and Neal Rosen in the lab
In the Clinic
Promising Results from the First-Ever Trial of a Drug that Blocks Cancer Gene KRAS

The drug, sotorasib, is targeted against a cancer-causing protein that has long been considered an “undruggable” target.
Colorectal Tumors in Young vs. Older Adults Are Biologically Similar, Says MSK Study

The largest, most comprehensive study of its kind from Memorial Sloan Kettering Cancer Center finds that the biology of colorectal cancer in people under 50 is very similar to the disease in older people and more aggressive treatment of younger patients may not be warranted.
MSK Kids patient Irene Dimatulac
Cancer Straight Talk: How MSK Supports Young Adults with Cancer

Learn how the Lisa and Scott Stuart Center for Adolescent and Young Adult Cancers at Memorial Sloan Kettering is transforming the experience, care, and outcomes of teens and young adults with cancer.